Additionally, changes in dietary intake that often accompany these medicationssuch as reduced fat consumption or altered meal timingcan independently affect bowel patterns
The ACC/AHA guideline recommends a lipid panel every 3-12 months during ongoing therapy to confirm adherence and assess whether the cardiovascular risk target is being met
For people on a GLP-1 weight loss protocol, there are additional considerations that make D3 optimization especially important
Perhaps, but not to such a degree, says Charlie Seltzer, M.D., a Philadelphia-based obesity specialist
Eur J Gastroenterol Hepatol (2014) 26(7):72532.10.1097/MEG.0000000000000104 160 ValentiniLWirthEKSchweizerUHengstermannSSchaperLKoernickeTet alCirculating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease
Yammine L, Green CE, Kosten TR, de Dios C, Suchting R, Lane SD, et al